Market revenue in 2023 | USD 27.3 million |
Market revenue in 2030 | USD 43.7 million |
Growth rate | 6.9% (CAGR from 2023 to 2030) |
Largest segment | Instruments |
Fastest growing segment | Software |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Reagents & Consumables, Software, Accessories, Services |
Key market players worldwide | Danaher Corp, BD, Sysmex Corp, Agilent Technologies, Apogee Enterprises Inc, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Wipro Ltd ADR, Diasorin SpA, Miltenyi Biotec, Sony Group Corp |
Instruments was the largest segment with a revenue share of 36.63% in 2023. Horizon Databook has segmented the Saudi Arabia flow cytometry market based on instruments, reagents & consumables, software, accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of Saudi Arabia flow cytometry market can primarily be attributed to various initiatives being undertaken by the government to expand the biotechnology sector in the country. Organizations such as the King Abdullah University of Science and Technology (KAUST) facilitate biotechnology R&D activities in Saudi Arabia.
Furthermore, increasing private and public partnerships for expanding biopharmaceutical industry in the country are anticipated to boost the demand for flow cytometry products in Saudi Arabia. For instance, in October 2019, Saudi Arabian Investment Authority (SAGIA) signed an MOU with Korea’s GL Rapha Co. to manufacture biological drugs worth USD 320 million in the country.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account